Medicine and Dentistry
COVID-19
100%
Parkinson's Disease
66%
COVID-19 Therapy
66%
Gut Microbiome
37%
Disease
36%
Artificial Respiration
34%
Heart Arrest
33%
Human Immunodeficiency Virus
33%
Microbiome
32%
Medical Research
30%
Biological Marker
29%
Formaldehyde
29%
microRNA
28%
Nephropathy
26%
DNA Extraction
23%
Odds Ratio
22%
Care Group
18%
Gut
18%
Clinical Research
16%
National Health Service
16%
Intensive Care Medicine
16%
Renal Failure
16%
Drug Megadose
16%
Mild Cognitive Impairment
16%
Progressive Supranuclear Palsy
16%
Cardiovascular System
16%
Pre-Analytical Phase
16%
Observational Study
16%
Uropathy
16%
Staphylococcal Bacteremia
16%
Small Nucleolar RNA
16%
Comorbidity
16%
Metabolomics
16%
Tocilizumab
16%
Next Generation Sequencing
16%
Rifampicin
16%
Acetylsalicylic Acid
16%
Placebo
16%
Personalized Medicine
16%
Infection
14%
Glomerular Filtration Rate
13%
Hypoxia
13%
Staphylococcus Aureus
11%
Intention-to-Treat Analysis
11%
Albuminuria
9%
Cardiovascular Disease
9%
Drug Transformation
8%
Diagnosis
8%
Cross Sectional Study
7%
Low Drug Dose
7%
Dexamethasone
7%
Recurrent Disease
7%
Antibiotic Therapy
7%
Adverse Event
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Corticosteroid
6%
Body Mass Index
6%
Biorepository
5%
Combination Therapy
5%
Logistic Regression Analysis
5%
Chronic Kidney Disease
5%
Hazard Ratio
5%
Biochemistry, Genetics and Molecular Biology
DNA Extraction
40%
Human Immunodeficiency Virus
33%
Microbiome
33%
Induced Pluripotent Stem Cell
33%
Cryopreservation
27%
RNA
20%
Blood Sampling
20%
Metabolic Pathway
20%
Real-Time Polymerase Chain Reaction
20%
Metabolite
19%
Fibroblast Culture
16%
Genetic Divergence
16%
DNA Sequence
16%
Cardiac Arrest
16%
Circular RNA
16%
Liquid
16%
Proteinase K
16%
Leukocyte
16%
Amplicon
16%
Peripheral Blood Mononuclear Cell
16%
Pre-Analytical Phase
16%
Reprogramming
16%
Enzyme
16%
Next Generation Sequencing
16%
Fibroblast
16%
Metabolomics
16%
Crystallization
16%
Gene Expression Profiling
16%
Glomerulus Filtration
16%
Transcriptomics
14%
Centrifugation
12%
Solution and Solubility
11%
Explant
11%
Fluorescence Spectroscopy
11%
Gene Expression
10%
Messenger RNA
8%
16S Ribosomal RNA
8%
Gene Sequence
8%
Genetics
8%
Glucocerebrosidase
8%
Pseudogene
8%
Sequence Homology
8%
Ficoll
8%
Coding Region
8%
Prevalence
8%
Phosphoribosyltransferase
8%
Genetic Risk
8%
Glucosylceramidase
8%
Blood Plasma
8%
Secretion (Process)
6%
Metagenomics
5%
Supernatant
5%
Cross Sectional Study
5%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
58%
Formaldehyde
33%
Infection
24%
Adverse Event
22%
Baricitinib
16%
RNA 16S
16%
Microbiome
16%
Acetylsalicylic Acid
16%
Exposure Assessment
16%
Xanthine
16%
Proteinase K
16%
Fixative
16%
Empagliflozin
16%
Levodopa-Induced Dyskinesia
16%
SARS Coronavirus
16%
Azithromycin
16%
Rifampicin
16%
Heart Arrest
16%
Staphylococcal Bacteremia
16%
Polycyclic Aromatic Hydrocarbon
16%
Placebo
16%
Comorbidity
16%
Microorganism
16%
Observational Study
16%
Dimethyl Sulfoxide
16%
Disease
16%
Biological Marker
14%
Staphylococcus Aureus
11%
Monoclonal Antibody
11%
Cardiovascular Disease
9%
Hair Analysis
8%
Cotinine
8%
Polychlorinated Biphenyl
8%
Epithelium Tumor
8%
Organic Compound
8%
4,4' Isopropylidenediphenol
8%
Janus Kinase Inhibitor
8%
All Cause Mortality
7%
Thrombosis
7%
Antibiotic Therapy
7%
Recurrent Disease
7%
Base
5%
Receptor
5%
COVID-19 Vaccine
5%
Heart Arrhythmia
5%
Glycoprotein
5%
Cryoprotective Agent
5%
Messenger RNA
5%
Survival Rate
5%